Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency

//Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency

Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency

The patients had a genetic disease called adenosine deaminase–deficient severe combined immune deficiency (ADA-SCID) — also known as bubble boy syndrome. Caused by a mutation on a vital gene, the disease weakens the immune system to the point where patients are very vulnerable to day-to-day infections.

By | 2019-02-25T17:10:18-04:00 February 25th, 2019|News|Comments Off on Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency

About the Author: